NPPA fixes prices of 15 more drugs

The National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling prices of 15 more drugs, including those used for treatment of heart ailments, infections, cancer, hypertension and pain relief.
In a notification, the drug price regulator said the prices of 15 scheduled formulations were fixed under the Drug Price Control Order.
Some of the medicines include anti-biotic Vancomycin, cancer treatment drug Etoposide, blood pressure medicine Noradrenaline and Digoxin used to treat heart ailments.
NPPA asked all manufacturers selling branded, generic or both versions of these medicines to adhere to its pricing guidelines.
The drug pricing regulator is mandated to fix/revise prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country, under the Drugs (Prices Control) Orders.

It is entrusted with recovering of amounts overcharged by manufacturers for the controlled drugs from the consumers for the controlled drugs. NPPA also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.